Free Trial
NASDAQ:MDRX

Veradigm (MDRX) Stock Price, News & Analysis

Veradigm logo
$4.85 +0.15 (+3.19%)
As of 07/3/2025 11:22 AM Eastern

About Veradigm Stock (NASDAQ:MDRX)

Key Stats

Today's Range
$4.01
$4.85
50-Day Range
$4.16
$4.85
52-Week Range
$3.00
$11.80
Volume
2,738 shs
Average Volume
333,765 shs
Market Capitalization
$525.09 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$13.00
Consensus Rating
Hold

Company Overview

Veradigm Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
59th Percentile Overall Score

MDRX MarketRank™: 

Veradigm scored higher than 59% of companies evaluated by MarketBeat, and ranked 140th out of 301 stocks in the business services sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Veradigm has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    Veradigm has received no research coverage in the past 90 days.

  • Read more about Veradigm's stock forecast and price target.
    • Short Interest

      There is no current short interest data available for MDRX.
    • Dividend Yield

      Veradigm does not currently pay a dividend.

    • Dividend Growth

      Veradigm does not have a long track record of dividend growth.

    • Short Interest

      There is no current short interest data available for MDRX.
    • News Sentiment

      Veradigm has a news sentiment score of 1.09. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.63 average news sentiment score of Business Services companies.
    • News Coverage This Week

      MarketBeat has tracked 2 news articles for Veradigm this week, compared to 2 articles on an average week.
    Receive MDRX Stock News and Ratings via Email

    Sign-up to receive the latest news and ratings for Veradigm and its competitors with MarketBeat's FREE daily newsletter.

    MDRX Stock News Headlines

    Veradigm Provides 2025 Financial & Business Update
    A new rule goes live in July — and the banks are quietly cashing in
    A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.
    See More Headlines

    MDRX Stock Analysis - Frequently Asked Questions

    Veradigm's stock was trading at $9.75 at the beginning of the year. Since then, MDRX stock has decreased by 50.3% and is now trading at $4.85.

    Veradigm Inc. (NASDAQ:MDRX) posted its quarterly earnings results on Thursday, November, 4th. The software maker reported $0.27 EPS for the quarter, beating the consensus estimate of $0.18 by $0.09. The business's revenue for the quarter was down 8.2% compared to the same quarter last year.

    Veradigm subsidiaries include these companies: ZappRx, HealthGrid, and Practice Fusion.

    Shares of MDRX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

    Based on aggregate information from My MarketBeat watchlists, some other companies that Veradigm investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Advanced Micro Devices (AMD), Adobe (ADBE), GE Aerospace (GE) and ServiceNow (NOW).

    Company Calendar

    Last Earnings
    11/04/2021
    Today
    7/07/2025
    Fiscal Year End
    12/31/2025

    Industry, Sector and Symbol

    Stock Exchange
    NASDAQ
    Industry
    Computer integrated systems design
    Sub-Industry
    Health Care Technology
    Current Symbol
    NASDAQ:MDRX
    Employees
    8,000
    Year Founded
    1986

    Price Target and Rating

    Average Stock Price Target
    $13.00
    High Stock Price Target
    $13.00
    Low Stock Price Target
    $13.00
    Potential Upside/Downside
    +168.0%
    Consensus Rating
    Hold
    Rating Score (0-4)
    2.00
    Research Coverage
    1 Analysts

    Profitability

    Trailing P/E Ratio
    N/A
    Forward P/E Ratio
    N/A
    P/E Growth
    N/A
    Pretax Margin
    N/A

    Debt

    Sales & Book Value

    Annual Sales
    $1.53 billion
    Price / Cash Flow
    N/A
    Price / Book
    N/A

    Miscellaneous

    Free Float
    105,175,000
    Market Cap
    $525.09 million
    Optionable
    No Data
    Beta
    0.78

    Social Links

    A Beginner's Guide to Investing in Cannabis Cover

    Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

    Get This Free Report

    This page (NASDAQ:MDRX) was last updated on 7/7/2025 by MarketBeat.com Staff
    From Our Partners